| |
| |
|
| Insider
Information: |
Wolff Henry Ward |
| Relationship: |
Director |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
207,058 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$108,455 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
207,058 |
|
|
| Total
Value |
$108,455 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sangamo Biosciences Inc |
SGMO |
Exec VP & CFO |
2015-12-12 |
206,829 |
|
0 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
Sr. VP Finance and CFO |
2006-11-30 |
229 |
2006-11-30 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2009-09-30 |
4 |
D |
$8.21 |
$18,333 |
D/D |
(2,233) |
88,329 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2011-03-31 |
4 |
D |
$8.33 |
$18,618 |
D/D |
(2,235) |
89,921 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2014-10-10 |
4 |
AS |
$10.10 |
$20,200 |
D/D |
(2,000) |
214,347 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2015-07-10 |
4 |
OE |
$3.45 |
$21,052 |
D/D |
6,102 |
205,974 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2014-11-10 |
4 |
AS |
$11.37 |
$22,748 |
D/D |
(2,000) |
213,353 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2014-09-10 |
4 |
AS |
$12.31 |
$24,620 |
D/D |
(2,000) |
216,347 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2019-03-12 |
4 |
OE |
$5.10 |
$25,500 |
D/D |
5,000 |
15,766 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2010-08-30 |
4 |
B |
$3.00 |
$27,000 |
D/D |
9,000 |
94,629 |
2.74 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2013-01-23 |
4 |
A |
$3.45 |
$27,600 |
D/D |
8,000 |
219,219 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exe VP & CFO |
• – – |
2008-12-31 |
4 |
D |
$3.48 |
$31,104 |
D/D |
(8,938) |
93,109 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2013-02-28 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
219,219 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2013-04-10 |
4 |
A |
$3.45 |
$34,500 |
D/D |
10,000 |
219,219 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2013-07-17 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
219,219 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2013-08-13 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
219,219 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2013-09-10 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
219,219 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2013-10-10 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
219,219 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2013-11-13 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
223,219 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2013-12-10 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
223,219 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2014-01-10 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
237,347 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2014-02-10 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
237,347 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2014-03-10 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
237,347 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2015-01-12 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
220,849 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2015-02-10 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
218,849 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2015-03-10 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
216,849 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Exec VP & CFO |
• – – |
2015-04-10 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
214,849 |
0 |
- |
|
96 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
